Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Novel first-in-human data presented on Medimmune cancer immunotherapy

March 20, 2012

Genmab submits protocol amendment for phase III ofatumumab trial

March 19, 2012

Mologen seeks approval for study of MGN-1703 in NSCLC

March 16, 2012

Oncothyreon starts phase I ONT-10 cancer vaccine trial

March 15, 2012

FDA clears IND application for phase III trial of melanoma vaccine

March 9, 2012

NME efficiently activates type I natural killer T cells

March 2, 2012

Johns Hopkins and ImmunoCellular Therapeutics enter licensing agreement for cancer antigen

March 1, 2012

OncoTherapy Science updates on cancer peptide vaccine pipeline

March 1, 2012

Advaxis reports data from first cohort in phase II ADXS-HPV trial

Feb. 28, 2012

Stem CentRx reports new APCDD1-binding antibodies

Feb. 28, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...